Travelers Companies (NYSE:TRV – Free Report) had its price objective increased by UBS Group from $205.00 to $225.00 in a research note published on Tuesday, Benzinga reports. UBS Group currently has a neutral rating on the insurance provider’s stock. TRV has been the subject of a number of other research reports. The Goldman Sachs Group […]